CompletedNot Applicable

Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients

France10 participantsStarted 2023-12-13

Plain-language summary

Single-center, prospective, translational, clinical-biological, multidisciplinary study

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Renal transplant patient * Patient converted from an anticalcineurin to belatacept Exclusion Criteria: * Opposition to data processing * Hemoglobin \< 9g/dL * Patient under judicial protection * Pregnant or breastfeeding woman